key: cord-0991650-keglyojg
authors: Qin, Pan; Luo, Wen-Ting; Su, Quan; Zhao, Pengwei; Zhang, Yuqi; Wang, Bin; Yang, Yong-Le; Huang, Yao-Wei
title: The porcine deltacoronavirus accessory protein NS6 is expressed in vivo and incorporated into virions
date: 2021-01-23
journal: Virology
DOI: 10.1016/j.virol.2021.01.011
sha: e1a014002538b2f872360b28c3f850f951b2c0c1
doc_id: 991650
cord_uid: keglyojg

Porcine deltacoronavirus (PDCoV) is one of the emerged coronaviruses posing a significant threat to the swine industry. Previous work showed the presence of a viral accessory protein NS6 in PDCoV-infected cells. In this study, we detected the expression of the NS6 protein in small intestinal tissues of PDCoV-infected piglets. In addition, SDS-PAGE and Western blot analysis of sucrose gradient-purified virions showed the presence of a 13-kDa NS6 protein. Further evidences of the presence of NS6 in the PDCoV virions were obtained by immunogold staining of purified virions with anti-NS6 antiserum, and by immunoprecipitation of NS6 from purified virions. Finally, the anti-NS6 antibody was not able to neutralize PDCoV in cultured cells. These data establish for the first time that the accessory protein NS6 is expressed during infection in vivo and incorporated into PDCoV virions.

In the past two decades, several newly emerged coronaviruses (CoVs), including the 31 severe acute respiratory syndrome coronavirus (SARS-CoV) (Zhong et al., 2003) , Middle 32

East respiratory syndrome coronavirus (MERS-CoV) (Zaki et al., 2012) , SARS-CoV-2 (Zhou 33 et al., 2020) , porcine deltacoronavirus (PDCoV) (Woo et al., 2012) , and swine enteric 34 alphacoronavirus (SeACoV) (Yang et al., 2019a; Yang et al., 2019b; Yang et al., 2020b) , 35 have caused respiratory or gastrointestinal diseases in humans or animals. They have posed 36 significant threats to public health or animal health. Among these, PDCoV (genus 37 Deltacoronavirus; subfamily Orthocoronavirinae; family Coronaviridae; order Nidovirales) 38 mainly causes acute diarrhea, vomiting, dehydration, and mortality in nursing pigs (Jung et 39 al., 2015) , and leads to a significant economic losses for the swine industry. Since being first 40 reported in Hong Kong in 2012 (Woo et al., 2012) , PDCoV has been detected in the United 41 single-stranded, positive-sense RNA genome, which has a 5′ cap structure and a 3′ poly (A) 47 and viral non-structural proteins from PDCoV-infected cells, the virions were purified by two 127 steps of ultracentrifugation. The absence of contamination with cellular proteins was 128 confirmed by WB using an anti-beta actin antibody (data not shown). 129 IEM was conducted to further confirm incorporation of NS6 into PDCoV particles by 130 immunogold labeling. No staining was observed when purified virions were incubated with 131 pre-immune rabbit serum (Fig. 3A) , whereas strong reactivity was observed with 132 hyperimmune rabbit serum (Figs. 3B and 3C) and anti-S1 antibodies (Figs. 3D-3F), shown by 133 the number of gold particles surrounding the virus envelope. Gold particles were clearly 134 associated with virions when incubated with the mouse anti-NS6 antiserum . 135

Moreover, we attempted to determine whether the anti-NS6 antibody could 136 immunoprecipitate the NS6 protein from purified virions. IP was performed with rabbit IgG 137 (as the negative control; Fig. 4A ), anti-N mAb (as the positive control) or anti-NS6-pt to 138 capture protein complexes, respectively, in mock-infected, PDCoV-infected LLC-PK1 cells, 139 or purified PDCoV particles ( Fig. 4A-4D ). WB analysis demonstrated that, while the 140 structural N protein could be pulled down by the anti-N mAb (Fig. 4B) , the NS6 protein was 141 also efficiently precipitated from PDCoV-infected cells or purified virions but not from the 142 mock-infected cells by the anti-NS6 antibody (Fig. 4C ). Therefore, these data suggest that the 143 NS6 protein is attached to the PDCoV virion. 144

In order to test whether immunization with NS6 could induce neutralizing antibodies 146 against PDCoV, we analyzed the neutralizing activity of the mouse anti-NS6 antiserum in 147 LLC-PK1 cells by the virus neutralizing assay. As determined by IFA, the hyperimmune 148 anti-PDCoV serum used as the positive control suppressed 100% of PDCoV infection at a 1:2 149 dilution and about 50% at a 1:256 dilution ( Fig. 5A ; the top four panels). In contrast, neither 150 the pre-immunized mouse serum used as the negative control nor the anti-NS6 antiserum at a 151 1:2 dilution showed the neutralizing activity against PDCoV ( Fig. 5A ; the lower four panels). 152

The IFA results were further supported by PDCoV RNA quantification (Fig. 5B ). The 153 anti-NS6 antiserum did not block PDCoV infection between 1:2 to 1:256 dilutions, whereas 154 the hyperimmune anti-PDCoV serum exhibited effective neutralizing activity in a 155 dose-dependent manner (Fig. 5B including as many as four putative genes for accessory proteins (Woo et al., 2012) . CoVs 162 accessory proteins are species specific and some (such as SARS-CoV ORF6, 7a, 7b and 9b 163 proteins) have been shown as minor components of virions (Huang et al., 2006; Schaecher et 164 al., 2007; Xu et al., 2009) . Interestingly, the SARS-CoV accessory ORF6, 7a, 7b and 9b 165 proteins are not required for virus replication (Liu et al., 2014) . Despite a recent increase in 166 attention, few studies have looked at the accessory proteins of PDCoV (Fang et al., 2017; 167 Fang et al., 2016) . Previous work has shown that PDCoV NS6 was expressed and distributed 168 in the cytoplasm during early virus infection and antagonizes IFN-β production in vitro (Fang 169 et al., 2018) . In addition, Zhang et al generated a NS6-null recombinant PDCoV mutant by 170 reverse genetics and showed that NS6 play a key role in promoting viral replication and 171 pathogenesis (Zhang et al., 2020) . However, whether the NS6 is expressed in target tissues of 172 infected pigs was not assessed yet. This study fills this gap, confirming detection of NS6 173

We further demonstrate that NS6 is incorporated into virus particles. First, we generated 175 and validated the specificity of anti-NS6 antibodies and compared their reactivity with 176 hyperimmune rabbit anti-PDCoV serum in WB analysis. The observed differences in band 177 intensity indicate that NS6 is an integral, though minor component of PDCoV virions. This 178 lower quantity may explain why detection of NS6 in purified virions required a higher 179 concentration (1:200) of anti-NS6 peptide antibody. Both the IEM and IP results offered 180 more visible evidence of NS6-specific antibodies reacting with PDCoV particles. However, 181 as no putative transmembrane domain was predicted by bioinformatics software, the pattern 182 or mechanism of NS6 protein assembly into virions remains for further study. 183

According to the previous reports, accessory proteins have been broadly implicated in 184 cell proliferation, programmed cell death, inducing ER stress as well as antagonizing IFN-β 185 production (Dedeurwaerder et al., 2014; Liu et al., 2014; Niemeyer et al., 2013; Yang et al., 186 2013) . Although recent research has confirmed that ectopic expression of NS6 antagonizes 187 IFN-β production (Fang et al., 2018) , a more thorough and accurate functional analysis of the 188 NS6 protein at the level of viral infection is needed. In this study, we also demonstrated that 189 J o u r n a l P r e -p r o o f described by Hofmann and Wyler for the purification of PEDV (Hofmann and Wyler, 1990) . 207

Briefly, PDCoV-infected LLC-PK1 cell cultures were harvested at 48 hours post-infection 208 (hpi), and intracellular virus was released by subjecting the cultures to three freeze-thaw 209 cycles, followed by centrifugation at 4000 × g for 30 min to remove coarse cell debris. 210

Virions in the supernatant were then pelleted by high-speed centrifugation (105,000 × g) at 211

4°C for 2 h, and resuspended in TNE (20 mM Tris-HCl, pH 7.2, 100 mM NaCl, 2 mM EDTA) 212 to 5% of the original volume. Virus preparations were layered onto two sucrose cushions (12 213 ml of 20% and 8 ml of 45%, prepared in TNE) and centrifuged at 146,000 × g at 4°C for 16 h. 214

The resulting band between the two sucrose concentrations was collected with a syringe, and 215 then used for analysis of virion proteins. 216

anti-NS6 polyclonal antibodies (pAb) 218

The putative NS6 gene was amplified from total RNAs extracted from PDCoV-infected 219 LLC-PK1 cells by one-step RT-PCR and subsequently cloned into the pET-28a (+) vector 220 (Novagen) with a polyhistidine tag at the carboxyl terminus between EcoRI and XhoI 221 restriction sites. The recombinant plasmid was verified by Sanger sequencing and 222 transformed into Rosetta (DE3) competent cells (Transgen biotech, China) . After induction 223 with 1 mM IPTG for 6 h, bacteria were collected by centrifugation (8000 × g, 15 min) and 224 lysed using the supersonic schizolysis method. The lysates were then centrifuged at 12000 × 225 g for 15 min at 4 °C to collect supernatants and precipitates (inclusion bodies). The 226 supernatants and precipitates were analyzed by SDS-PAGE. The resulting protein was 227 subsequently purified using Ni-NTA His•Bind® Resin (Transgen biotech, China) . 228

Six-week-old female BALB/c mice were immunized with 20 μg of the purified NS6 protein 229 in the complete Freund's adjuvant. The subsequent three immunizations were carried out at 230 3-week intervals with 20 μg of the same antigens mixed with the incomplete Freund's 231 adjuvant. One week after the last immunization, anti-NS6 polyclonal antibodies were 232 collected in the serum. Indirect enzyme-linked immunosorbent assay (ELISA), IFA and WB 233 were used to determine the titer and specificity of the antibodies as described previously (Qin 234 et al., 2017; Wang et al., 2018) . 235 4.4. Generation of three rabbit pAbs specific to NS6, M or S subunit 1 (S1) of PDCoV 236

Two distinct short peptides predicted to suitable for immunization were selected from 237 corresponding to aa 15-28, and acetyl-CIRPSLQVILEDELN-amide corresponding to aa 239 81-94). Two New Zealand white rabbits were immunized initially with 0.1 mg mixed 240 peptides-keyhole limpet haemocyanin (KLH) conjugate in complete Freund's adjuvant. 241

Booster injections with the same amount of the conjugate emulsified in incomplete Freund's 242 adjuvant were given at three-week intervals, and sera were collected one week after the third 243 booster injection. IFA and WB analysis were used to test the specificity of the 244 anti-NS6-peptide pAb (anti-NS6-pt). 245

The PDCoV M protein antigenic peptide (acetyl-DTFHYTFKKPVESNNDPE-amide) 246 that has been described previously (Chen et al., 2015) was used to produce anti-peptide pAb 247 specific to M as mentioned above. The PDCoV S1 (aa 1-574) with a six-histidine tag was 248 expressed by baculovirus system in SF9 insect cells as described previously (Wang et al., 249 2017) . The purified proteins were used to immunize rabbits, and anti-S1 pAb were harvested 250 at 55 days postimmunization. 251

One New Zealand white rabbit was immunized four times with purified PDCoV 253 particles, emulsified with Freund's complete adjuvant for the first injection and with Freund's 254 incomplete adjuvant for the rest. Serum samples were collected periodically to measure the 255 specific IgG by ELISA, and pre-immunization sera were collected for use as negative 256 controls. 257

All of the generated pAbs or antisera described above are summarized in Table 1 . with goat anti-mouse IgG conjugated to 10-nm gold particles (#G7652, Sigma) or goat 293 anti-rabbit IgG conjugated to 10-nm gold particles (#G7402, Sigma). Grids were washed five 294 times with PBS for 2 min per time, and then washed five times with Milli-Q water for 2 min 295 per time, respectively. After the washing, samples were negatively stained with 3% uranyl 296 acetate for 5 min and with lead citrate for 3 min and observed under electron microscopy. 297

The animal experiment conducted in neonatal pigs was approved by the Experimental 299

Animal Ethics Committee of Zhejiang University (no. ZJU20170026). Six, 3-day-old 300 conventional piglets, shown to be RNA-negative for PEDV, PDCoV and TGEV in fecal 301 DMEM orally as negative controls, whereas piglets in groups B were each challenged orally 303 with 2 ml of PDCoV at 1×10 6 plaque-forming units (PFU)/ml. At 3 days post-infection (dpi), 304 all piglets were euthanized and jejunum and ileum were collected and fixed in 10% (v/v) 305 phosphate-buffered formalin for IHC staining with mouse anti-NS6 antiserum. Rabbit anti-M 306 antibodies prepared by our lab were used as a positive control. 307

Purified PDCoV particles, mock-infected, or PDCoV-infected LLC-PK1 cell were lysed 309 in lysis buffer (25 mM Tris-HCl, 200 mM NaCl, 10 mM NaF, 1 mM Na 3 VO 4 , 25 mM 310 β-glycerophosphate, 1% NP40) containing a protease inhibitor cocktail (Bimake, USA) and 311 incubated on a shaker for 30 min at 4°C. The lysates were then cleared by centrifugation at 312 14,000 × g for 10 min. The supernatants were precipitated with anti-NS6-pt, rabbit IgG and 313 anti-N mAb, respectively, and incubated with gentle rocking overnight at 4°C. Protein A 314 beads (Beyotime, China) washed with lysis buffer were added to supernatant fractions and 315 incubated with gentle rocking for 2 h at 4 °C. After washing four times with lysis buffer, 316 isolated immunoprecipitated proteins were boiled 10 min with PAGE sample loading buffer 317

The pre-immune mouse serum, the anti-NS6 mouse serum, and the hyperimmune 320 anti-PDCoV serum were heat-inactivated for 30 min at 65°C followed by 2-fold serial 321 dilutions from 1:2 to 1:256 with DMEM, respectively. The diluted samples were 322 subsequently mixed with 100 TCID 50 (50% tissue culture infectious dose) of PDCoV and 323 incubated for 60 min at 37°C followed by inoculation and culture of LLC-PK1 cell 324 monolayers per dilution for 48 h. Neutralization activity was evaluated by IFA using the 325 anti-N antibody, and by comparison of viral RNA titers between different treatments using 326 one-step quantitative reverse-transcription polymerase chain reaction (qRT-PCR) targeting 327 the PDCoV M gene as described previously . 328

The serine, threonine, and tyrosine phosphorylation sites in NS6 were predicted by the 330 3995-4008. 426 Xu, K., Zheng, B.J., Zeng, R., Lu, W., Lin, Y.P., Xue, L., Li, L., Yang, L.L., Xu, C., Dai, J., 427 Wang, F., Li, Q., Dong, Q.X., Yang, R.F., Wu, J.R., Sun, B., 2009 . Severe acute respiratory 428 syndrome coronavirus accessory protein 9b is a virion-associated protein. Virology 388, 429 279-285. 430 Yang, Y., Zhang, L., Geng, H., Deng, Y., Huang, B., Guo, Y., Zhao, Z., Tan, W., 2013 were measured by qRT-PCR, which were then compared between different treatments 500 and represented by the relative infectivity (viral RNA copies of tested sera / viral 501 RNA copies of pre-immune sera × 100%). Data represent mean values plus standard 502 deviation (SD) of at least 3 replicates. 503 J o u r n a l P r e -p r o o f 

We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.

We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed.

We further confirm that the order of authors listed in the manuscript has been approved by all of us.

We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property.

We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). He is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author and which has been configured to accept email from yhuang@zju.edu.cn

Pan Qin

cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of 458

A pneumonia outbreak associated with a new 463 coronavirus of probable bat origin